ULnar Nerve ECHographic Observation (ULNECHO)

Ulnar Neuropathies Clinical Trial

— ULNECHO  

Official title:

ULnar Nerve ECHographic Observation (ULNECHO)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03209947
• Other study ID #: 29BRC17.0085 ULNECHO
• Status: Completed
• Phase: N/A
• First received: July 4, 2017
• Last updated: April 20, 2018
• Start date: September 22, 2017
• Est. completion date: February 15, 2018

Study information

• Verified date: April 2018
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There is currently no consensus on the normal ultrasound surface of the ulnar nerve at the elbow. The goal of this study is to study the ulnar nerve surface at the elbow in a population of asymptomatic subjects

Description:

100 elbows from 50 patients will be included, from a population of asymptomatic subjects, in order to measure the frequency of ulnar nerve which surface is >8,3 mm².

The measures will be realized centered on the epicondyle : 2 cm higher, and 2 cm lower with 2 echographs (ESAOTE) and 2 observers. An inter and intra observer study will also be realized to determine the reproducibility and reliability of the measurements.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: February 15, 2018
• Est. primary completion date: February 15, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient aged 18 -to 80 years or older

• Patient without any current or previous pathology on the ulnar nerve

• Patients would be able to consent

Exclusion Criteria:

• Patient under administrative supervision or legal guardianship

Related Conditions & MeSH terms

• Ulnar Neuropathies

Intervention

Diagnostic Test:
• Ulnar nerve Ultrasound
No drug and no placebo were used in this arm. Patients were followed by Ultrasound approach by measure of ulnar nerve surface

Locations

Country	Name	City	State
France	CHRU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measure of ulnar nerve surface > 8,3 mm ² frequency by Ultrasound		1 day
Secondary	Correlation ulnar nerve surface measure of by two doctors		1 day